The stock has a 36-month beta value of 0.29. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for ALLR is 1.06M, and at present, short sellers hold a 8.92% of that float. On October 02, 2024, the average trading volume of ALLR was 439.61K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ALLR) stock’s latest price update
Allarity Therapeutics Inc (NASDAQ: ALLR) has experienced a decline in its stock price by -16.11 compared to its previous closing price of 2.11. However, the company has seen a fall of -20.27% in its stock price over the last five trading days. accesswire.com reported 2024-10-01 that LOS ANGELES, CA / ACCESSWIRE / October 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Allarity Therapeutics, Inc. (“Allarity” or “the Company”) (NASDAQ:ALLR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between May 17, 2022 and July 19, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before November 12, 2024.
ALLR’s Market Performance
ALLR’s stock has fallen by -20.27% in the past week, with a monthly drop of -67.49% and a quarterly drop of -72.79%. The volatility ratio for the week is 11.12% while the volatility levels for the last 30 days are 20.81% for Allarity Therapeutics Inc The simple moving average for the past 20 days is -44.85% for ALLR’s stock, with a -98.40% simple moving average for the past 200 days.
ALLR Trading at -58.99% from the 50-Day Moving Average
After a stumble in the market that brought ALLR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.73% of loss for the given period.
Volatility was left at 20.81%, however, over the last 30 days, the volatility rate increased by 11.12%, as shares sank -64.78% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -64.02% lower at present.
During the last 5 trading sessions, ALLR fell by -20.27%, which changed the moving average for the period of 200-days by -99.48% in comparison to the 20-day moving average, which settled at $3.05. In addition, Allarity Therapeutics Inc saw -99.46% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ALLR
Current profitability levels for the company are sitting at:
- -151.04 for the present operating margin
- 0.73 for the gross margin
The net margin for Allarity Therapeutics Inc stands at -113.8. The total capital return value is set at -0.83. Equity return is now at value -121.82, with -52.54 for asset returns.
Based on Allarity Therapeutics Inc (ALLR), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -11.89. The debt to equity ratio resting at 0.07. The interest coverage ratio of the stock is 132.16.
Currently, EBITDA for the company is -17.89 million with net debt to EBITDA at 1.06. When we switch over and look at the enterprise to sales, we see a ratio of -137.57. The receivables turnover for the company is 0.07for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.01.
Conclusion
To sum up, Allarity Therapeutics Inc (ALLR) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
